[Federal Register Volume 84, Number 141 (Tuesday, July 23, 2019)]
[Notices]
[Pages 35388-35389]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-15593]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Advisory Committee on Breast Cancer in Young Women (ACBCYW); 
Meeting

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC 
announces the following meeting for the Advisory Committee on Breast 
Cancer in Young Women (ACBCYW). This meeting is open to the public, 
limited only by room space, and audio web conference lines (80 audio 
and web conference lines available). The public is also welcome to 
listen to the meeting by accessing the call-in number, 1-800-857-4868, 
passcode, 1218986 (80 lines are available). The web conference access 
is https://adobeconnect.cdc.gov/radjn2o1shbb/.
    Online Registration Required: All ACBCYW Meeting participants must 
register for the meeting online at least 7 business days in advance at 
https://www.cdc.gov/cancer/breast/what_cdc_is_doing/conference.htm. 
Please complete all the required fields before submitting your 
registration and submit no later than August 9, 2019. All visitors are 
required to present a valid form of picture identification issued by a 
state, federal or international government. As required by the Federal 
Property Management Regulations, all persons entering in or on Federal 
controlled property and their packages, briefcases, and other 
containers in their immediate possession are subject to being x-rayed 
and inspected. Federal law prohibits the knowing possession or the 
causing to be present of firearms, explosives and other dangerous 
weapons and illegal substances.

DATES: The meeting will be held on August 19, 2019, 8:30 a.m. to 5:00 
p.m., EDT and August 20, 2019, 8:30 a.m. to 12:00 Noon, EDT.

ADDRESSES: 4770 Buford Highway, Atlanta, Georgia 30341.
    The teleconference access is 1-800-857-4868; passcode, 1218986. The 
web conference access is https://adobeconnect.cdc.gov/radjn2o1shbb/.

FOR FURTHER INFORMATION CONTACT: Temeika L. Fairley, Ph.D., Designated 
Federal Officer, National Center for Chronic Disease Prevention and 
Health Promotion, CDC, 5770 Buford Hwy. NE, Mailstop K52, Atlanta, 
Georgia, 30341,

[[Page 35389]]

Telephone (770) 488-4518, Fax (770) 488-4760. Email: [email protected].

SUPPLEMENTARY INFORMATION: 
    Purpose: The committee provides advice and guidance to the 
Secretary, HHS; the Assistant Secretary for Health; and the Director, 
CDC, regarding the formative research, development, implementation and 
evaluation of evidence-based activities designed to prevent breast 
cancer (particularly among those at heightened risk) and promote the 
early detection and support of young women who develop the disease. The 
advice provided by the Committee will assist in ensuring scientific 
quality, timeliness, utility, and dissemination of credible appropriate 
messages and resource materials.
    Matters To Be Considered: The agenda will include discussions on 
current and emerging topics related to breast cancer in young women. 
These will include public health communication, breast cancer in young 
women digital and social media campaign, CDC updates, and updates from 
the field. Agenda items are subject to change as priorities dictate.
    The Chief Operating Officer, Centers for Disease Control and 
Prevention, has been delegated the authority to sign Federal Register 
notices pertaining to announcements of meetings and other committee 
management activities, for both the Centers for Disease Control and 
Prevention and the Agency for Toxic Substances and Disease Registry.

Sherri Berger,
Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2019-15593 Filed 7-22-19; 8:45 am]
BILLING CODE 4163-18-P